Piperine inhibits the growth and motility of triple-negative breast cancer cells

Cancer Letters

Volumn 357, Issue 1, 2015, Pages 129-140

  Greenshields, Anna L ^a   Doucette, Carolyn D ^a   Sutton, Kimberly M ^a   Madera, Laurence ^a   Annan, Henry ^b   Yaffe, Paul B ^a   Knickle, Allison F ^a   Dong, Zhongmin ^b   Hoskin, David W ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b SAINT MARY S UNIVERSITY   (Canada)

Author keywords

Apoptosis; Breast cancer; Metastasis; Piperine; Xenograft

Indexed keywords

CASPASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; MESSENGER RNA; PIPERINE; PROTEIN KINASE B; PROTEIN P53; 1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; AMIDE; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; FEMALE; GAMMA RADIATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; INHIBITION KINETICS; METASTASIS INHIBITION; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; MCF 7 CELL LINE; NONOBESE DIABETIC MOUSE; SCID MOUSE; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

MUS; PIPER NIGRUM;

ALKALOIDS; ANIMALS; APOPTOSIS; BENZODIOXOLES; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MCF-7 CELLS; MICE; MICE, INBRED NOD; MICE, SCID; PIPERIDINES; POLYUNSATURATED ALKAMIDES; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84920391506     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.017     Document Type: Article

References (60)

1. Kaefer C.M., Milner J.A. The role of herbs and spices in cancer prevention. J. Nutr. Biochem 2008, 19:347-361.
2. Johri R.K., Zutshi U. An Ayurvedic formulation 'Trikatu' and its constituents. J. Ethnopharmcol 1992, 37:85-91.
3. Meghwal M., Goswami T.K. Piper nigrum and piperine: an update. Phytother. Res 2013, 27:1121-1130.
4. Madhavi B.B., Nath A.R., Banji D., Madhu M.N., Ramalingam R., Swetham D. Extraction, identification, formulation and evaluation of piperine in alginate beads. Int. J. Pharm. Sci 2009, 1:156-161.
5. Bukhari I.A., Pivac N., Alhumayyd M.S., Mahesar A.L., Gilani A.H. The analgesic and anticonvulsant effects of piperine in mice. J. Physiol. Pharmacol 2013, 64:789-794.
6. Taqvi S.I., Shah A.J., Gilani A.H. Blood pressure lowering and vasomodulator effects of piperine. J. Cardiovasc. Pharmacol 2008, 52:452-458.
7. Ononiwu I.M., Ibeneme C.E., Ebong O.O. Effects of piperine on gastric acid secretion in albino rats. Afr. J. Med. Sci 2002, 31:293-295.
8. Platel K., Srinivasan K. Influence of dietary spices or their active principles on digestive enzymes of small intestinal mucosa in rats. Int. J. Food Sci. Nutr 1996, 47:55-59.
9. Platel K., Srinivasan K. Influence of dietary spices or their active principles on pancreatic digestive enzymes in albino rats. Nahrung 2000, 44:42-46.
10. Badmaev V., Majeed M., Prakash L. Piperine derived from black pepper increases plasma levels of coenzyme Q10 following oral supplementation. J. Nutr. Biochem 2000, 11:109-113.
11. Bhardwaj R.K., Glaeser H., Becquemont L., Klotz U., Gupta S.K., Fromm M.F. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther 2002, 302:645-650.
12. Reen R.K., Singh J. In vitro and in vivo inhibition of pulmonary cytochrome P450 activities by piperine, a major ingredient of piper species. Indian J. Exp. Biol 1991, 29:568-673.
13. Volak L.P., Ghirmai S., Cashman J.R., Court M.H. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab. Dispos 2008, 36:1594-1605.
14. Chonpathompikunlert P., Wattanathorn J., Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease. Food Chem. Toxicol 2010, 48:798-802.
15. Selvendiran K., Banu S.M., Sakthisekaran D. Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Clin. Chim. Acta 2004, 350:73-78.
16. Ying X., Chen X., Cheng S., Shen Y., Peng L., Xu H.Z. Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte. Int. Immunopharmacol 2013, 17:293-299.
17. Doucette C.D., Hilchie A.L., Liwski R., Hoskin D.W. Piperine, a dietary phytochemical, inhibits angiogenesis. J. Nutr. Biochem 2013, 24:231-239.
18. Lai L.H., Fu Q.H., Liu Y., Jiang K., Guo Q.M., Chen Q.Y., et al. Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol. Sin 2012, 33:523-530.
19. Samykutty A., Shetty A.V., Dakshinamoorthy G., Bartik M.M., Johnson G.L., Webb B., et al. Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen-dependent and androgen-independent prostate cancer cells. PLoS ONE 2013, 8:e65889.
20. Pradeep C.R., Kuttan G. Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clin. Exp. Metastasis 2002, 19:703-708.
21. Amir E., Freedman O.C., Seruga B., Evans D.G. Assessing women at high risk of breast cancer: a review of risk assessment models. J. Natl. Cancer Inst 2010, 102:680-691.
22. Klijn J.G., Berns E.M., Bontenbal M., Foekens J. Cell biological factors associated with the response of breast cancer to systemic treatment. Cancer Treat. Rev 1993, 19(Suppl. B):45-63.
23. Cancer Genome Atlas Network Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70.
24. Perez E.A. Current management of metastatic breast cancer. Semin. Oncol 1999, 26(Suppl. 12):1-10.
25. Yagita M., Ieki Y., Onishi R., Huang C.L., Adachi M., Horiike S., et al. Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer. Int. J. Oncol 1998, 13:91-96.
26. Donnelly J.G. Pharmacogenetics in cancer chemotherapy: balancing toxicity and response. Ther. Drug Monit 2004, 26:231-235.
27. Bush J.A., Li G. Cancer chemoresistance: the relationship between p53 and multidrug transporters. Int. J. Cancer 2002, 98:323-330.
28. Foulkes W.D., Smith I.E., Reis-Filho J.S. Triple-negative breast cancer. N. Engl. J. Med 2010, 363:1938-1948.
29. Pasqualini J.R., Schatz B., Varin C., Nruyen B.L. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer. J. Steroid Biochem. Mol. Biol 1992, 41:323-329.
30. Okumura Y., Narukawa M., Iwasaki Y., Ishikawa A., Matsuda H., Yoshikawa M., et al. Activation of TRPV1 and TRPA1 by black pepper components. Biosci. Biotechnol. Biochem 2010, 74:1068-1072.
31. Clark A.S., West K., Streicher S., Dennis P.A. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther 2002, 1:707-717.
32. Twiddy D., Brown D.G., Adrain C., Jukes R., Martin S.J., Cohen G.M., et al. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J. Biol. Chem 2004, 279:19665-19682.
33. Tester A.M., Ruangpanit N., Anderson R.L., Thompson E.W. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits. Clin. Exp. Metastasis 2000, 18:553-560.
34. Huovinen M., Loikkanen J., Myllynen P., Vähäkangas K.H. Characterization of human breast cancer cell lines for the studies on p53 in chemical carcinogenesis. Toxicol. In Vitro 2011, 25:1007-1017.
35. Do M.T., Kim H.G., Choi J.H., Khanal T., Park B.H., Tran T.P., et al. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem 2013, 141:2591-2599.
36. Polyak K., Waldman T., He T.C., Kinzler K.W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996, 10:1945-1952.
37. Kakarala M., Brenner D.E., Korkaya H., Cheng C., Tazi K., Ginestier C., et al. Targeting breast stem cells with the cancer preventative compounds curcumin and piperine. Breast Cancer Res. Treat 2010, 122:777-785.
38. Cioce M., Gherardi S., Viglietto G., Strano S., Blandino G., Muti P., et al. Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle 2010, 9:2878-2887.
39. Luca A.C., Mersch S., Deenen R., Schmidt S., Messner I., Schäfer K.L., et al. Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS ONE 2013, 8:e59689.
40. Piyachaturawat P., Glinsukon T., Toskulkao C. Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol. Lett 1983, 16:351-359.
41. Malumbres M., Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 2009, 9:153-167.
42. Bracken A.P., Ciro M., Cocito A., Helin K. E2F target genes: unraveling the biology. Trends Biochem. Sci 2004, 29:409-417.
43. Boutros R., Dozier C., Ducommun B. The when and wheres of CDC25 phosphatases. Curr. Opin. Cell Biol 2006, 18:185-191.
44. Waga S., Li R., Stillman B. p53-induced p21 controls DNA replication. Leukemia 1997, 11:321-323.
45. Ouyang D., Zeng L., Pan H., Xu L., Wang Y., Liu K., et al. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food Chem. Toxicol 2013, 60:424-430.
46. Zhang X., Li X.R., Zhang J. Current status and future perspectives of PI3K and mTOR inhibitor as anticancer drugs in breast cancer. Curr. Cancer Drug Targets 2013, 13:175-187.
47. Chai J., Du C., Wu J.W., Kyin S., Wang X., Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000, 406:855-862.
48. Yaffe P.B., Doucette C.D., Walsh M., Hoskin D.W. Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells. Exp. Mol. Pathol 2013, 94:109-114.
49. Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. J. Pharm. Sci 2007, 96:2181-2196.
50. Liotta L.A. Gene products which play a role in cancer invasion and metastasis. Breast Cancer Res. Treat 1988, 11:113-124.
51. Kang Y. New tricks against an old foe: molecular dissection of metastasis tissue tropism in breast cancer. Breast Dis 2006-2007, 26:129-138.
52. Kohrmann A., Kammerer U., Kapp M., Dietl J., Anacker J. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer 2009, 9:188.
53. Pradeep C.R., Kuttan G. Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int. Immunopharmacol 2004, 4:795-803.
54. Kubiatowski T., Jang T., Lachyankar M.B., Salmonsen R., Nabi R.R., Quesenberry P.J., et al. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J. Neurosurg 2001, 95:480-488.
55. Shukla S., Maclennan G.T., Hartman D.J., Fu P., Resnick M.I., Gupta S. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int. J. Cancer 2007, 121:1424-1432.
56. Agil F., Munagala R., Jeyabalan J., Vadhanam M.V. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett 2013, 334:133-141.
57. Koleva I.I., van Beek T.A., Soffers A.E., Dusemund B., Rietjens I.M. Alkaloids in the human food chain - natural occurrence and possible adverse effects. Mol. Nutr. Food Res 2011, 56:30-52.
58. Suresh D., Srinivasan K. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J. Med. Res 2010, 131:682-691.
59. Liu J., Bi Y., Luo R., Wu X. Simultaneous UFLC-ESI-MS/MS determination of piperine and piperlongumine in rat plasma after oral administration of alkaloids from Piper longum L.: application to pharmacokinetic studies in rats. J. Chromatogr. B 2011, 879:2885-2890.
60. Huang Q., Yu H., Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J. Food Sci 2010, 75:R50-R57.